The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury
Abstract Background Preclinical studies highlight the importance of endogenous cannabinoids (endocannabinoids; eCBs) in neurodegeneration. Yet, prior observational studies focused on limited outcome measures and assessed only few eCB compounds while largely ignoring the complexity of the eCB system....
Main Authors: | Shiraz Vered, Alexa S. Beiser, Liron Sulimani, Sharon Sznitman, Mitzi M. Gonzales, Hugo J. Aparicio, Charles DeCarli, Matthew R. Scott, Saptaparni Ghosh, Gil M. Lewitus, David Meiri, Sudha Seshadri, Galit Weinstein |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-023-01301-x |
Similar Items
-
Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
by: Jie Xiao, et al.
Published: (2023-04-01) -
Endocannabinoid Signaling for GABAergic-Microglia (Mis)Communication in the Brain Aging
by: Jorge Carrera, et al.
Published: (2021-02-01) -
Sleep, Glial Function, and the Endocannabinoid System: Implications for Neuroinflammation and Sleep Disorders
by: Josué Camberos-Barraza, et al.
Published: (2024-03-01) -
The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
by: Tiziana Bisogno, et al.
Published: (2021-09-01) -
The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
by: Adi Eitan, et al.
Published: (2023-09-01)